Trial intelligence / Profile preview

Adipose-derived stem cell-based tissue regeneration (AdSC technique)

jRCT1090220126Completed

Sponsor
LTT Bio-Pharma Co., Ltd.
Start
May 2013
Countries
1
01

Overview

Open-label, single-arm trial in soft tissue injury and Cardiac damage, sponsored by LTT Bio-Pharma Co., Ltd. Primary endpoint: efficiency of the differentiation method of cardiomyocytes and other cell types. Started May 2013; status: completed.

02

Conditions

soft tissue injuryCardiac damage

Beyond the preview

Go deeper on jRCT1090220126.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1090220126.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call